These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7659385

  • 1. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
    Chen SL, Uehara T, Morozumi T, Yamagami H, Kusuoka H, Nishimura T.
    Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M.
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H, Kawasaki S, Yoneyama S, Hyougo T, Kamitani T, Takahashi T, Kunishige H.
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H.
    Eur J Nucl Med; 1992 Feb; 19(9):775-82. PubMed ID: 1396872
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K, Sugihara H, Umamoto I, Harada Y, Shiga K, Nakamura T, Nakagawa T, Azuma A, Kohno Y, Katsume H.
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [Abstract] [Full Text] [Related]

  • 6. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M, Kurihara T, Usami M, Honda M.
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [Abstract] [Full Text] [Related]

  • 7. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
    Nishimura T, Nagata S, Uehara T, Morozumi T, Ishida Y, Nakata T, Iimura O, Kurata C, Wakabayashi Y, Sugihara H, Otsuki K, Wada T, Koga Y.
    Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
    [Abstract] [Full Text] [Related]

  • 8. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K, Sugihara H, Ito K, Matsumoto K, Taniguchi Y, Terada K, Nakagawa T, Shima T, Kuribayashi T, Ochiai M.
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [Abstract] [Full Text] [Related]

  • 9. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H, Nakata T, Han S, Takahashi N, Hashimoto A, Tsuchihashi K, Nagao K, Tanaka S, Shimamoto K, Iimura O.
    J Cardiol; 1994 Apr; 24(1):35-43. PubMed ID: 8158529
    [Abstract] [Full Text] [Related]

  • 10. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy.
    Shimonagata T, Nishimura T, Uehara T, Hayashida K, Kumita S, Ohno A, Nagata S, Miyatake K.
    Nucl Med Commun; 1993 Nov; 14(11):1005-13. PubMed ID: 8290156
    [Abstract] [Full Text] [Related]

  • 11. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E, Kudoh T, Hattori N, Inubushi M, Magata Y, Konishi J, Matsumori A, Nohara R, Sasayama S, Yoshibayashi M, Tamaki N.
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [Abstract] [Full Text] [Related]

  • 12. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C, Shuke N, Okizaki A, Yamamoto W, Sato J, Ishikawa Y, Ohta T, Hasebe N, Kikuchi K, Aburano T.
    Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
    [Abstract] [Full Text] [Related]

  • 13. 123I-labelled BMIPP fatty acid myocardial scintigraphy in patients with hypertropic cardiomyopathy: SPECT comparison with stress 201Tl.
    Taki J, Nakajima K, Bunko H, Shimizu M, Taniguchi M, Hisada K.
    Nucl Med Commun; 1993 Mar; 14(3):181-8. PubMed ID: 8455908
    [Abstract] [Full Text] [Related]

  • 14. [Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: assessment by dual-isotope SPECT with thallium-201 and iodine-123 beta-methyl fatty acid analogue].
    Hase M, Nakata T, Yonekura S, Tsuchihashi K, Kobayashi H, Nagao K, Tanaka S, Kubota M, Tsuda T, Iimura O.
    Kaku Igaku; 1993 May; 30(5):529-39. PubMed ID: 8336412
    [Abstract] [Full Text] [Related]

  • 15. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.
    Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, Kawai H, Kaneko M.
    J Nucl Med; 1992 Jan; 33(1):6-13. PubMed ID: 1530969
    [Abstract] [Full Text] [Related]

  • 16. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.
    Taki J, Nakajima K, Matsunari I, Bunko H, Takada S, Tonami N.
    Eur J Nucl Med; 1995 Dec; 22(12):1385-92. PubMed ID: 8586083
    [Abstract] [Full Text] [Related]

  • 17. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
    Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M.
    J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
    [Abstract] [Full Text] [Related]

  • 18. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy.
    Shimizu M, Yoshio H, Ino H, Taki J, Nakajima K, Bunko H, Takeda R.
    Int J Cardiol; 1996 Apr 19; 54(1):51-9. PubMed ID: 8792185
    [Abstract] [Full Text] [Related]

  • 19. [Serial change of 123I-BMIPP SPECT imaging during recovery from stunned myocardium after acute myocardial infarction--correlation with 201Tl and two-dimensional echocardiography].
    Nakano A, Kondo M, Tokunaga S, Akiyama K, Mori Y, Nosue Y, Makita T, Tanio H, Shimono Y.
    Kaku Igaku; 1995 Mar 19; 32(3):227-33. PubMed ID: 7739152
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
    Morozumi T, Ishida Y, Hori M, Kamada T, Yamagami H, Kozuka T, Kusuoka H, Nishimura T.
    Kaku Igaku; 1993 Sep 19; 30(9):1037-47. PubMed ID: 8230824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.